This study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
Astrid Knott, PhD
Advertisement
Articles by Astrid Knott, PhD
Advertisement
Latest Updated Articles
- Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and Outcomes
Published: February 8th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
FDA Approves Gazyva for Active Lupus Nephritis
3
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
4
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
5
